Stability and preservation of a new formulation of epoprostenol sodium for treatment of pulmonary arterial hypertension
Olivier Lambert, Dirk BandillaActelion Pharmaceuticals Ltd, Allschwil, SwitzerlandBackground: The aim of this study was to evaluate the stability and microbiological properties of a formulation of epoprostenol sodium with L-arginine and sucrose excipients (epoprostenol AS).Methods: The stability of...
I tiakina i:
| Ngā kaituhi matua: | , |
|---|---|
| Hōputu: | Pukapuka |
| I whakaputaina: |
Dove Medical Press,
2012-09-01T00:00:00Z.
|
| Ngā marau: | |
| Urunga tuihono: | Connect to this object online. |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ipurangi
Connect to this object online.3rd Floor Main Library
| Tau karanga: |
A1234.567 |
|---|---|
| Tārua 1 | Wātea |